Type 1 OI is characterized by mild bone fragility, blue sclera, and reduced collagen production. Mutations in the COL1A1 and COL1A2 genes, responsible for encoding type I collagen protein, contribute to 70%-80% of OI cases [6]. This evidence concerns the gene COL1A1 and osteogenesis imperfecta.